(Q53230105)

12 May 2018

title

Cyclin D2 is overexpressed in proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma. (English)

1 reference

12 May 2018

0 references

1 reference

1 reference

9

Mitsune Tanimoto

1 reference

12 May 2018

author name string

Takuro Igawa

1

1 reference

12 May 2018

Yasuharu Sato

2

1 reference

12 May 2018

Katsuyoshi Takata

3

1 reference

12 May 2018

Soichiro Fushimi

4

1 reference

12 May 2018

Maiko Tamura

5

1 reference

12 May 2018

Naoya Nakamura

6

1 reference

12 May 2018

Yoshinobu Maeda

7

1 reference

12 May 2018

Yorihisa Orita

8

1 reference

12 May 2018

Tadashi Yoshino

10

1 reference

12 May 2018

publication date

24 August 2011

1 reference

12 May 2018

published in

Cancer Science

1 reference

12 May 2018

volume

102

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

2103-2107

1 reference

12 May 2018

G1 phase progression: cycling on cue

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Cell cycle, CDKs and cancer: a changing paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

The retinoblastoma protein pathway and the restriction point

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Cycling to cancer with cyclin D1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Clinical significance of CD38 expression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukaemia to non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Regulation and function of cyclin D2 in B lymphocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Functional analysis of the human cyclin D2 and cyclin D3 promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

The function of p27 KIP1 during tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Repression of p15INK4b expression by Myc through association with Miz-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02046.X

10.1111/J.1349-7006.2011.02046.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018